But while they cool the air effectively, they also tend to strip the room of moisture, leaving the indoor environment ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) to treat bullous ...

As the Philadelphia region experiences its first heat wave of 2025, it’s important to stay safe as temperatures rise into the ...

A deep dive into shellfish allergy symptoms, causes and risks. From itchy hives to full-blown anaphylaxis, why seafood ...

This approval marks the eighth disease indication for Dupixent as a new alternative for patients—many of whom are elderly and ...

Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi (SNY) on Friday announced that the U.S. Food and Drug Administration (FDA) ...

Sanofi SNY and its partner, Regeneron REGN, announced that the FDA has approved their blockbuster medicine, Dupixent ...

Key findings of subgroup analyses included an observed increased psoriasis risk in patients without atopic comorbidities (HR 1.42, 95% CI 1.06-1.89) and those with pretreatment immunoglobulin E (IgE) ...

While it’s relatively easy to recognize the signs of asthma in children, doctors warn that it’s not so clear-cut in adults. In fact, many adults develop the illness later in life but have yet to be ...

They included adults evaluated at the Severe Asthma Clinic of Bichat University Hospital (Paris, France) during a 1-day hospital stay between May 2022 and January 2024. Sensitization was defined by a ...

Individuals with a high lipid accumulation product index had a 34% increased probability of developing asthma than those with a low LAP index. Asthma incidence in adults is positively associated with ...